Accuray appoints Steve La Neve chief executive
Accuray appointed medtech executive Steve La Neve chief executive as Suzanne Winter retired and the company began an operational transformation.
Evidence notes
- La Neve became CEO on 20 October 2025.
- Suzanne Winter retired after six years and remained as an adviser through November.
- Accuray paired the leadership change with a strategic and operational transformation plan.
Company context
Accuray develops and manufactures robotic radiosurgery and image-guided radiation therapy systems, including the CyberKnife and helical TomoTherapy and Radixact platforms.